<DOC>
	<DOCNO>NCT01550393</DOCNO>
	<brief_summary>RATIONALE : Studying sample urine patient cancer laboratory may help doctor identify biomarkers related cancer . PURPOSE : This clinical trial study biomarkers urine patient Wilms tumor .</brief_summary>
	<brief_title>Biomarkers Urine Samples From Patients With Wilms Tumor</brief_title>
	<detailed_description>OBJECTIVES : - To validate prognostic performance specific-candidate Wilms tumor marker measure urinary concentration use enzyme-linked immunosorbent assay ( ELISAs ) urine specimen collect diagnosis 50 patient favorable histology Wilms tumor relapse 50 patient relapse . OUTLINE : Urine specimens analyze use enzyme-linked immunosorbent assay ( ELISAs ) biomarkers .</detailed_description>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<mesh_term>Wilms Tumor</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Urine specimen collect diagnosis select patient stage IIIII Wilms tumor , local nonlocal site disease relapse Clinical patient information ( urinalysis/macro , age , gender , congenital defects/syndromes , comorbidities , tumor stage , size , pathology , therapy , outcome ) available PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>stage II Wilms tumor</keyword>
	<keyword>stage III Wilms tumor</keyword>
	<keyword>recurrent Wilms tumor childhood kidney tumor</keyword>
</DOC>